Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls

Biological Psychiatry

Volumn 40, Issue 5, 1996, Pages 353-360

  Leyton, Marco ^a,b   Bélanger, Claude ^a   Martial, Johanne ^a   Beaulieu, Serge ^a   Corin, Ellen ^a   Pecknold, John ^a   Kin, Ng Ying ^a   Meaney, Michael ^a   Thavundayil, Joseph ^a   Larue, Suzanne ^a   Nair, Vasavan ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiovascular; Cortisol; Panic disorder; Paroxetine; Serotonin; Stress

Indexed keywords

HYDROCORTISONE; PAROXETINE;

ADULT; AGORAPHOBIA; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; STRESS; THROMBOCYTE;

EID: 0030245654     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00452-1     Document Type: Article

References (53)

1. Armitage P, Berry G (1987): Statistical Methods in Medical Research, 2nd ed. Oxford: Blackwell Scientific Publications.
2. Arora RC, Fichtner CG, O'Connor F, Crayton JW (1993): Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci 53:919-928.
3. Asmundson GJG, Stein MB (1994): Resting cardiovascular measures in patients with panic disorder and social phobia and healthy control subjects: Relationship to habitual exercise frequency. Anxiety 1:26-30.
4. Banki CM (1977): Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women. J Neural Transm 41:135-143.
5. Barlow DH (1988): Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. New York: The Guilford Press.
6. Cacioppo JT (1994): Social neuroscience: Autonomie, neuroendocrine, and immune response to stress. Psychophysiology 31:113-128.
7. Cloninger CR (1986): A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 3:167-226.
8. Cloninger CR (1987): A systematic method for clinical description and classification of personality variants: A proposal. Arch Gen Psychiatry 44:573-588.
9. Cloninger CR, Przybeck TR, Svrakic DM (1991): The tridimensional personality questionnaire: U.S. normative data. Psychol Rep 69:1047-1057.
10. Dienstbier RA (1989): Arousal and physiological toughness: implications for mental and physical health. Psychol Rev 96:84-100.
11. Edwards E, Kornich W, Houtten PV, Kenn FA (1992): Presynaptic serotonin mechanisms in rats subjected to inescapable shock. Neuropsychopharmacology 31:323-330.
12. Evans L, Schneider P, Ross-Lee L, et al (1985): Plasma serotonin levels in agoraphobia. Am J Psychiatry 142:267.
13. 3H-imipramine binding in panic disorder patients and healthy controls. J Psychiatr Neurosci 19:109-113.
14. Finlay-Jones R, Brown GW (1981): Types of stressful life events and the onset of anxiety and depressive disorders. Psychol Med 11:803-815.
15. Frankenhaeuser M (1971): Behavior and circulating catecholamines. Brain Res 31:241-262.
16. Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J (1987): The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry 144:1320-1323.
17. Gurguis GNM, Mefford IN, Uhde TW (1991): Hypothalamicpituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites. Biol Psychiatry 30:502-506.
18. 3H]paroxetine binding to rat corticall membranes. Eur J Pharmacol 118;107-114.
19. Habert I, Graham D, Langer SZ (1986): Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes. Eur J Pharmacol 122:197-204.
20. Hamilton M (1959): The assessment of anxiety states by rating. Br J Med Psychology 32:50-55.
21. Harris FA, Tyron WW (1983): Some necessary and sufficient conditions for the experimental induction of learned helplessness. J Soc Clin Psychology 1:15-26.
22. Hoehn-Saric R, McLeod DR, Zimmerli WD (1991): Psychophysiological response patterns in panic disorder. Acta Psychiatr Scand 83:4-11.
23. Hudgens GA, Chatterton RT, Torre J Jr, et al (1989): Hormonal and psychological profiles in response to a written examination. In Breznitz S, Zinder O (eds), Molecular Biology of Stress. New York: Liss, pp 265-275.
24. 3H]paroxetine binding on human platelets. Biol Psychiatry 36:281-291.
25. Kirschbaum C, Wüst S, Hellhammer DH (1992): Consistent sex differences in cortisol responses to psychological stress. Psychosom Med 54:648-657.
26. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry 24:299-309.
27. 1A receptor responsivity in anxiety disorders and depression. Prog Neuropsychopharmacol Biol Psychiatry 15:723-733.
28. Linnoila M, Virkkunen RM (1991): Monoamines, glucose metabolism and impulse control. In Sandler M, Coppen A, Harnett S (eds), 5-Hydroxytryptamine in Psychiatry: A Spectrum of Ideas. Oxford: Oxford University Press, pp 258-278.
29. 3H]paroxetine binding in panic disorder. J Affective Disord 33:117-122.
30. Mathews KA, Rakaczky CJ, Stoney CM, Manuck SB (1987): Are cardiovascular responses to behavioral stressors a stable individual difference variable in childhood? Psychophysiology 24:464-473.
31. McElroy SL, Hudson JI, Pope HG Jr, Keck PE Jr, Aizley HG (1992): The DSM-III-R impulse control disorders not elsewhere classified: Clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry 149:318-327.
32. McNally RJ, Lukach BM (1992): Are panic attacks traumatic Stressors? Am J Psychiatry 149:824-826.
33. 3H]imipramine to human platelet membranes. Eur J Pharmacol 96:303-309.
34. Meyerhoff JL, Oleshansky MA, Mougey EH (1988): Psychologic stress increases plasma levels of prolactin, cortisol, and POMC-derived peptides in man. Psychosom Med 50:295-303.
35. Middleton HC (1990): Cardiovascular dystonia in recovered panic patients. J Affective Disord 19:229-236.
36. Munaro NI (1978): The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology 26:270-276.
37. Post RM, Weiss SRB (1988): Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In Kalivas PW, Barnes CD (eds), Sensitization in the Nervous System, Caldwell, NJ: Telford Press, pp 257-292.
38. Post RM (1992): Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010.
39. Roth WT, Telch MJ, Taylor CB, et al (1986): Autonomic characteristics of agoraphobia with panic attacks. Biol Psychiatry 21:1133-1154.
40. Roth WT, Margraf J, Ehlers A, et al (1992): Stress test reactivity in panic disorder. Arch Gen Psychiatry 49:301-310.
41. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986): The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
42. Saviotti FM, Grandi S, Savron G, et al (1991): Characterological traits of recovered patients with panic disorder and agoraphobia. J Affective Disord 23:113-117.
43. Segonzac A, Schoemaker H, Langer SZ (1987): Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: A clue to the imipramine selectivity paradox. J Neurochem 48:331-339.
44. Spitzer RL (1987): Structured Clinical Interview for DSM-III-R. New York: Biometrics Research Department, New York State Psychiatric Institute.
45. Stein JM, Papp LA, Klein DF, et al (1992): Exercise tolerance in panic disorder patients. Biol Psychiatry 32:281-287.
46. Stein MB, Asmundson GJG (1994): Autonomic function in panic disorder: Cardiorespiratory and plasma catecholamine responsivity to multiple challenges of the autonomic nervous system. Biol Psychiatry 36:548-558.
47. Stein MB, Tancer ME, Uhde TW (1992): Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Arch Gen Psychiatry 49:311-317.
48. 3H]paroxetine binding to platelets of patients with social phobia: Comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 37:224-228.
49. Targum SD (1992): Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 17:453-458.
50. Torgersen S (1987): Genetic factors in anxiety disorders. Arch Gen Psychiatry 40:1085-1089.
51. Weissman NJ, Shear MK, Kramer-Fox R, Devereux RB (1987): Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks. Am J Med 82:880-888.
52. Yeragani VK, Balon R, Pohl R, et al (1990a): Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand 81:554-559.
53. Yeragani VK, Mein PC, Pohl R, Balon R, Desai N, Golec S (1990b): Heart rate and blood pressure changes during postural change and isometric handgrip exercise in patients with panic disorder and normal controls. Acta Psychiatr Scand 81:9-13.